Prefrontal Glutamatergic Modulation by NAC and MBCT for Depression in Youth

NCT07464886 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Mild Depression

Interventions

DRUG: N-acetylcysteine
BEHAVIORAL: Mindfulness-based cognitive therapy
DRUG: Placebo
BEHAVIORAL: Sham mindfulness-based intervention

Sponsor

University of Cincinnati

Collaborators

[object Object]